This chilling discovery suggests foreign invaders played a role. New archaeological finds add to evidence that the Maya city of Tikal in Guatemala was once ruled by people from Teotihuacan in ...

Investors in these stocks should be very aware that early-stage biotech stocks have huge upside but also bust potential, and to invest within your risk tolerance accordingly. Billy Duberstein and ...

China’s central bank is boosting cash injection via one of its policy tools as it seeks to safeguard the world’s second-largest economy from the impact of punitive US tariffs. The People’s ...

The recently announced expansion will add to the roughly 400 jobs already promised in central Ohio by the biotech company and bring its total local investment to $1.4 billion. The expansion is on ...

Fuel injection systems are high-precision electro-mechanical systems with tight tolerances that operate under very high pressures. All the fuel has to squeeze out of injectors with tiny outlets in ...

A newly devised universal prompt injection technique can break the safety guardrails of all major generative AI models, AI security firm HiddenLayer says. Called Policy Puppetry, the attack relies on ...

The round, which was majorly equity, also saw participation from Huddle, Campus Fund, Blume Founders Fund, and angel investors, including Nexus Venture’s Nitin Sharma and Northpoint Capital’s Sameer ...

A death row inmate had an extremely haunting 10-word plea to his victim's family before receiving the lethal injection. On Wednesday morning (23 April), Moises Sandoval Mendoza received the lethal ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Called Etiome, the biotech wants to take on a slew of medical conditions, from Parkinson’s disease and rheumatoid arthritis to the common liver condition known as metabolic dysfunction-associated ...

Young is one of more than 1,000 dog owners participating in a first-of-its-kind clinical trial at more than 70 facilities around the country and spearheaded by Bay Area biotech company Loyal.